These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 25559827)

  • 21. [Comparison of restenosis rate of bare-metal and drug-eluting stents in cardiac allograft vasculopathy].
    Cardona M; Mirabet S; Martín V; Martí V; Sabaté M; Bayés-Genís A
    Med Clin (Barc); 2012 May; 138(13):562-4. PubMed ID: 22177259
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic Value of Biomarkers in Cardiac Allograft Vasculopathy following Heart Transplantation: A Literature Review.
    Habibi S; Ghaffarpasand E; Shojaei F; Alihashemi M; Kahe F; Zahedi Tajrishi F; Chi G
    Cardiology; 2020; 145(11):693-702. PubMed ID: 32892195
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Usefulness and safety of percutaneous coronary interventions for cardiac transplant vasculopathy.
    Tanaka K; Li H; Curran PJ; Takano Y; Arbit B; Currier JW; Yeatman LA; Kobashigawa JA; Tobis JM
    Am J Cardiol; 2006 Apr; 97(8):1192-7. PubMed ID: 16616025
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug-eluting stents may not reduce target lesion revascularization in cardiac allograft vasculopathy.
    Park KE; Huo T; Muller KE; Aranda JM; Hill JA; Anderson RD
    J Interv Cardiol; 2014 Feb; 27(1):80-5. PubMed ID: 24383617
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Percutaneous coronary artery revascularization procedures in pediatric heart transplant recipients: A large single center experience.
    Turner ME; Addonizio LJ; Richmond ME; Zuckerman WA; Vincent JA; Torres AJ; Collins MB
    Catheter Cardiovasc Interv; 2016 Nov; 88(5):797-803. PubMed ID: 27083510
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiac allograft vasculopathy: current concepts.
    Ventura HO; Mehra MR; Smart FW; Stapleton DD
    Am Heart J; 1995 Apr; 129(4):791-9. PubMed ID: 7900633
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug-Eluting Balloons-A New Tool in the Treatment of Cardiac Allograft Vasculopathy: A Case Series.
    Skoric B; Bulum J; Cikes M; Jurin H; Lovric D; Ljubas-Macek J; Samardzic J; Pasalic M; Milicic D
    Transplant Proc; 2017 Sep; 49(7):1675-1677. PubMed ID: 28838462
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recurrence of in-stent restenosis in cardiac allograft vasculopathy following implantation of a sirolimus-eluting stent.
    Wessely R; Pache J; Schömig A
    Transpl Int; 2005 Sep; 18(9):1113-5. PubMed ID: 16101733
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endothelial dysfunction and cardiac allograft vasculopathy.
    Colvin-Adams M; Harcourt N; Duprez D
    J Cardiovasc Transl Res; 2013 Apr; 6(2):263-77. PubMed ID: 23135991
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microvascular coronary arterial vasculopathy--predictive value of endomyocardial biopsy.
    Lozano MD
    Z Kardiol; 2000; 89 Suppl 9():IX/54-7. PubMed ID: 11151794
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Angina pectoris in patients who underwent stent implantations for severe atherosclerotic coronary lesions 16 years after heart transplantation].
    Yamada A; Ishii Y; Kakizawa Y; Ishige A; Ueno H; Omichi C; Tanaka T; Nagashima H; Kanmatsuse K; Endo M
    Kyobu Geka; 2007 Oct; 60(11):969-73. PubMed ID: 17926899
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Role of Vascular Imaging in Guiding Routine Percutaneous Coronary Interventions: A Meta-Analysis of Bare Metal Stent and Drug-Eluting Stent Trials.
    Alsidawi S; Effat M; Rahman S; Abdallah M; Leesar M
    Cardiovasc Ther; 2015 Dec; 33(6):360-6. PubMed ID: 26363283
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Percutaneous coronary interventions with stents in cardiac transplant recipients.
    Bader FM; Kfoury AG; Gilbert EM; Barry WH; Humayun N; Hagan ME; Thomas H; Renlund D
    J Heart Lung Transplant; 2006 Mar; 25(3):298-301. PubMed ID: 16507423
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevention and treatment of coronary artery vasculopathy.
    Crespo-Leiro MG; Marzoa-Rivas R; Barge-Caballero E; Paniagua-Martín MJ
    Curr Opin Organ Transplant; 2012 Oct; 17(5):546-50. PubMed ID: 22941320
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ST-elevation myocardial infarction following heart transplantation as an unusual presentation of coronary allograft vasculopathy: a case report.
    Peter S; Hulme O; Deuse T; Vrtovec B; Fearon WF; Hunt S; Haddad F
    Transplant Proc; 2013 Mar; 45(2):787-91. PubMed ID: 23498821
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Percutaneous coronary interventions in cardiac allograft vasculopathy: a single-center experience.
    Colombo P; Bruschi G; Sacco A; Oreglia J; De Marco F; Colombo T; Botta L; Macera F; Turazza F; Frigerio M; Martinelli L; Klugmann S
    Transplant Proc; 2010 May; 42(4):1286-90. PubMed ID: 20534283
    [TBL] [Abstract][Full Text] [Related]  

  • 37. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).
    Ormiston J; Webster M; Stewart J; Vrolix M; Whitbourn R; Donohoe D; Knape C; Lansky A; Attizzani GF; Fitzgerald P; Kandzari DE; Wijns W
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1026-34. PubMed ID: 24055443
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiac allograft vasculopathy: a review.
    Ramzy D; Rao V; Brahm J; Miriuka S; Delgado D; Ross HJ
    Can J Surg; 2005 Aug; 48(4):319-27. PubMed ID: 16149368
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term follow up after coronary sirolimus drug-eluting stent implantation for cardiac transplant arteriopathy.
    Yoon EJ; Haeusslein E; Brent B
    J Invasive Cardiol; 2006 Apr; 18(4):184-5. PubMed ID: 16729397
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnosis and management of cardiac allograft vasculopathy.
    Ortega-Legaspi JM; Bravo PE
    Heart; 2022 Apr; 108(8):586-592. PubMed ID: 34340994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.